Get more replies from employers
Send a job-specific resume in minutes.
Genesis Molecular AI is seeking an experienced ML infrastructure engineer to lead the engineering efforts on our AI platform, focusing on scalable distributed infrastructure for training, inference, and evaluation across multiple clusters and clouds.
You will optimize GPU performance, accelerate workloads, and collaborate with researchers and scientists to advance our generative and predictive AI models for molecular space.
We’re a tight-knit team of proven drug hunters, deep learning researchers, and software engineers united by a common mission — drive AI innovation in biochemistry, discovering and developing groundbreaking therapies for patients suffering from severe disorders. Genesis AI team is focused on developing foundation models for small molecule drug discovery by conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, as well as engineering robust software systems that enable running large scale simulations and training generative and predictive AI models designed to learn from all kinds of molecular data, leveraging our cluster with 1000s of GPUs and 10,000s of CPUs.
We’re seeking experienced ML infrastructure engineers to join the team and lead engineering efforts focused on driving forward our ML research agenda for generative modeling of molecular systems, which is instrumental to our mission. As an engineer at Genesis, you will lead rapid iteration on our AI platform and infrastructure, unlocking the next level of performance, efficiency, and scale that was not previously possible. You will build massively distributed training and inference pipelines, core MLOps tools and frameworks, and optimize GPU operations to speed up ML models. Genesis is a highly-collaborative and cross functional environment, and you will work in close partnership with our exceptional engineers, researchers, and scientists.
Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. Our generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis is backed by premier AI and life science investors, including a16z, NVIDIA, Rock Springs Capital, Menlo Ventures, T. Rowe Price, Fidelity, and Radical Ventures. Genesis has also signed category-leading AI-pharma deals, the most recent of which was a significant expansion with Incyte (see coverage in Forbes and GEN) with a total potential deal value of several billion dollars. Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.